UniProt ID | LRP8_HUMAN | |
---|---|---|
UniProt AC | Q14114 | |
Protein Name | Low-density lipoprotein receptor-related protein 8 | |
Gene Name | LRP8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 963 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. Secreted. Isoforms that contain the exon coding for a furin-type cleavage site are proteolytically processed, leading to a secreted receptor fragment.. |
|
Protein Description | Cell surface receptor for Reelin (RELN) and apolipoprotein E (apoE)-containing ligands. LRP8 participates in transmitting the extracellular Reelin signal to intracellular signaling processes, by binding to DAB1 on its cytoplasmic tail. Reelin acts via both the VLDL receptor (VLDLR) and LRP8 to regulate DAB1 tyrosine phosphorylation and microtubule function in neurons. LRP8 has higher affinity for Reelin than VLDLR. LRP8 is thus a key component of the Reelin pathway which governs neuronal layering of the forebrain during embryonic brain development. Binds the endoplasmic reticulum resident receptor-associated protein (RAP). Binds dimers of beta 2-glycoprotein I and may be involved in the suppression of platelet aggregation in the vasculature. Highly expressed in the initial segment of the epididymis, where it affects the functional expression of clusterin and phospholipid hydroperoxide glutathione peroxidase (PHGPx), two proteins required for sperm maturation. May also function as an endocytic receptor. Not required for endocytic uptake of SEPP1 in the kidney which is mediated by LRP2 (By similarity).. | |
Protein Sequence | MGLPEPGPLRLLALLLLLLLLLLLQLQHLAAAAADPLLGGQGPAKDCEKDQFQCRNERCIPSVWRCDEDDDCLDHSDEDDCPKKTCADSDFTCDNGHCIHERWKCDGEEECPDGSDESEATCTKQVCPAEKLSCGPTSHKCVPASWRCDGEKDCEGGADEAGCATLCAPHEFQCGNRSCLAAVFVCDGDDDCGDGSDERGCADPACGPREFRCGGDGGGACIPERWVCDRQFDCEDRSDEAAELCGRPGPGATSAPAACATASQFACRSGECVHLGWRCDGDRDCKDKSDEADCPLGTCRGDEFQCGDGTCVLAIKHCNQEQDCPDGSDEAGCLQGLNECLHNNGGCSHICTDLKIGFECTCPAGFQLLDQKTCGDIDECKDPDACSQICVNYKGYFKCECYPGYEMDLLTKNCKAAAGKSPSLIFTNRHEVRRIDLVKRNYSRLIPMLKNVVALDVEVATNRIYWCDLSYRKIYSAYMDKASDPKEQEVLIDEQLHSPEGLAVDWVHKHIYWTDSGNKTISVATVDGGRRRTLFSRNLSEPRAIAVDPLRGFMYWSDWGDQAKIEKSGLNGVDRQTLVSDNIEWPNGITLDLLSQRLYWVDSKLHQLSSIDFSGGNRKTLISSTDFLSHPFGIAVFEDKVFWTDLENEAIFSANRLNGLEISILAENLNNPHDIVIFHELKQPRAPDACELSVQPNGGCEYLCLPAPQISSHSPKYTCACPDTMWLGPDMKRCYRAPQSTSTTTLASTMTRTVPATTRAPGTTVHRSTYQNHSTETPSLTAAVPSSVSVPRAPSISPSTLSPATSNHSQHYANEDSKMGSTVTAAVIGIIVPIVVIALLCMSGYLIWRNWKRKNTKSMNFDNPVYRKTTEEEDEDELHIGRTAQIGHVYPAAISSFDRPLWAEPCLGETREPEDPAPALKELFVLPGEPRSQLHQLPKNPLSELPVVKSKRVALSLEDDGLP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
83 (in isoform 2) | Ubiquitination | - | 68.02 | - | |
85 | O-linked_Glycosylation | EDDCPKKTCADSDFT CCCCCCCCCCCCCCC | 21.03 | 55826491 | |
118 | Phosphorylation | CPDGSDESEATCTKQ CCCCCCCCCCCCCCC | 37.21 | - | |
123 | Phosphorylation | DESEATCTKQVCPAE CCCCCCCCCCCCCHH | 21.84 | - | |
176 | N-linked_Glycosylation | PHEFQCGNRSCLAAV CCEECCCCCCEEEEE | 40.08 | UniProtKB CARBOHYD | |
238 | Phosphorylation | QFDCEDRSDEAAELC EECCCCCCHHHHHHH | 52.72 | - | |
253 | O-linked_Glycosylation | GRPGPGATSAPAACA CCCCCCCCCHHHHHH | 31.19 | OGP | |
261 | O-linked_Glycosylation | SAPAACATASQFACR CHHHHHHHHHHHHCC | 27.07 | OGP | |
441 | N-linked_Glycosylation | RIDLVKRNYSRLIPM HHHHHHHCHHHHHHH | 33.15 | UniProtKB CARBOHYD | |
475 | Phosphorylation | DLSYRKIYSAYMDKA ECCHHHHHHHHHHCC | 7.12 | 29083192 | |
476 | Phosphorylation | LSYRKIYSAYMDKAS CCHHHHHHHHHHCCC | 19.18 | 29083192 | |
478 | Phosphorylation | YRKIYSAYMDKASDP HHHHHHHHHHCCCCH | 10.41 | 29083192 | |
483 | Phosphorylation | SAYMDKASDPKEQEV HHHHHCCCCHHHCEE | 61.25 | 29083192 | |
518 | N-linked_Glycosylation | IYWTDSGNKTISVAT EEEECCCCCEEEEEE | 42.10 | UniProtKB CARBOHYD | |
520 | Phosphorylation | WTDSGNKTISVATVD EECCCCCEEEEEEEE | 23.60 | 23403867 | |
522 | Phosphorylation | DSGNKTISVATVDGG CCCCCEEEEEEEECC | 15.78 | 23403867 | |
525 | Phosphorylation | NKTISVATVDGGRRR CCEEEEEEEECCCEE | 19.58 | 23532336 | |
538 | N-linked_Glycosylation | RRTLFSRNLSEPRAI EEECCCCCCCCCCEE | 46.88 | UniProtKB CARBOHYD | |
567 | 2-Hydroxyisobutyrylation | GDQAKIEKSGLNGVD CCHHHHHHCCCCCCC | 53.98 | - | |
595 | Phosphorylation | GITLDLLSQRLYWVD CEEHHHHHHHHHHHC | 22.13 | 24719451 | |
664 (in isoform 2) | Ubiquitination | - | 5.33 | 21906983 | |
686 (in isoform 2) | Phosphorylation | - | 17.01 | - | |
698 (in isoform 4) | Ubiquitination | - | 49.14 | 21906983 | |
768 | Phosphorylation | PGTTVHRSTYQNHST CCCEEECCCCCCCCC | 19.31 | 24043423 | |
769 | Phosphorylation | GTTVHRSTYQNHSTE CCEEECCCCCCCCCC | 29.14 | 24043423 | |
770 | Phosphorylation | TTVHRSTYQNHSTET CEEECCCCCCCCCCC | 14.47 | 24043423 | |
772 | N-linked_Glycosylation | VHRSTYQNHSTETPS EECCCCCCCCCCCCC | 22.21 | UniProtKB CARBOHYD | |
774 | Phosphorylation | RSTYQNHSTETPSLT CCCCCCCCCCCCCCE | 35.17 | 24043423 | |
775 | Phosphorylation | STYQNHSTETPSLTA CCCCCCCCCCCCCEE | 36.01 | 24043423 | |
777 | Phosphorylation | YQNHSTETPSLTAAV CCCCCCCCCCCEEEC | 20.47 | 24043423 | |
779 | Phosphorylation | NHSTETPSLTAAVPS CCCCCCCCCEEECCC | 45.85 | 24043423 | |
781 | Phosphorylation | STETPSLTAAVPSSV CCCCCCCEEECCCCC | 19.53 | 24043423 | |
781 | O-linked_Glycosylation | STETPSLTAAVPSSV CCCCCCCEEECCCCC | 19.53 | OGP | |
786 | Phosphorylation | SLTAAVPSSVSVPRA CCEEECCCCCCCCCC | 36.45 | 24043423 | |
786 | O-linked_Glycosylation | SLTAAVPSSVSVPRA CCEEECCCCCCCCCC | 36.45 | OGP | |
787 | Phosphorylation | LTAAVPSSVSVPRAP CEEECCCCCCCCCCC | 16.61 | 24043423 | |
789 | Phosphorylation | AAVPSSVSVPRAPSI EECCCCCCCCCCCCC | 28.49 | 24043423 | |
807 | N-linked_Glycosylation | TLSPATSNHSQHYAN CCCCCCCCCCHHCCC | 34.18 | UniProtKB CARBOHYD | |
866 | Phosphorylation | MNFDNPVYRKTTEEE CCCCCCCCCCCCCCC | 13.98 | 21945579 | |
868 (in isoform 3) | Ubiquitination | - | 41.95 | 21906983 | |
868 (in isoform 1) | Ubiquitination | - | 41.95 | 21906983 | |
868 | Ubiquitination | FDNPVYRKTTEEEDE CCCCCCCCCCCCCCC | 41.95 | 2190698 | |
869 | Phosphorylation | DNPVYRKTTEEEDED CCCCCCCCCCCCCCC | 30.37 | 23186163 | |
870 | Phosphorylation | NPVYRKTTEEEDEDE CCCCCCCCCCCCCCC | 44.42 | 26471730 | |
890 (in isoform 3) | Phosphorylation | - | 4.97 | 27642862 | |
921 | Ubiquitination | EDPAPALKELFVLPG CCCCHHHHHHCCCCC | 55.25 | - | |
956 | Phosphorylation | KSKRVALSLEDDGLP CCCEEEEEECCCCCC | 21.70 | 29514088 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LRP8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRP8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
608446 | Myocardial infarction 1 (MCI1) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...